000 | 00898nam a2200265 4500 | ||
---|---|---|---|
003 | KMLcat | ||
008 | 151012b xxu||||| |||| 00| 0 eng d | ||
020 | _a9241547081 | ||
041 | _aEng | ||
082 |
_a615.1 _bQUA |
||
245 |
_aQuality assurance of pharmaceuticals _ba compendium of guidelines and related materials,vol. 2 |
||
250 | _a2nd Updated ed. | ||
260 |
_c2007 _aGeneva _bWHO _g2007 |
||
300 |
_aiv, 409 p. _bill. _c24 cm. |
||
650 | _aPHARMACEUTICAL PREPARATIONS | ||
655 |
_aDrug and narcotic control-standards _910664 |
||
655 |
_aBiological products-standards _910665 |
||
655 |
_aDrug industry-standards _910668 |
||
655 |
_aGuidelines _94505 |
||
655 |
_aPharmaceutical preparations-standards _910653 |
||
655 |
_aQuality control _910631 |
||
655 |
_aRisk assessment-methods _910582 |
||
856 | _uhttp://apps.who.int/iris/handle/10665/43532 | ||
942 |
_cSPR _2ddc |
||
999 |
_c4557 _d4557 |